Ami B Patel

US Patent:

20210148893, May 20, 2021

Filed:

May 4, 2018

Appl. No.:

16/610893

Inventors:

- Exton PA, US
Indranil NANDI - New Providence NJ, US
Ami C. PATEL - Doylestown PA, US
Ismael J. HIDALGO - Exton PA, US

International Classification:

G01N 33/50

Abstract:

The invention provides methods for determining in vitro bioequivalence of a sucralfate suspension sample to a sucralfate suspension RLD.

US Patent:

20190031743, Jan 31, 2019

Filed:

Jan 27, 2017

Appl. No.:

16/071898

Inventors:

- South San Francisco CA, US
Ryan CIRZ - San Mateo CA, US
Monica SCHWARTZ - South San Francisco CA, US
Kristina BENDER - South San Francisco CA, US
Shuang WU - South San Francisco CA, US
Felix FINDEISEN - South San Francisco CA, US
Malavika KANNUSWAMY - South San Francisco CA, US
Dante RICCI - South San Francisco CA, US
Ami PATEL - Foster City CA, US

International Classification:

C07K 16/12
C07K 16/00
G01N 33/569
G01N 33/543

Abstract:

Provided are assays or methods for identifying antibodies that bind to microorganisms, e.g., pathogenic microorganisms, such as bacteria other infectious agents. In some embodiments, the provided methods for identifying an antibody that binds the target microorganism involves gel encapsulation of antibody-producing cells in gel microdroplets with a target microorganism. Also provided are antibodies produced by the method. Also provided are antibodies that bind a conserved region or epitope across variants or species of